These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25146514)

  • 21. Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity?
    Horimoto AM; da Costa IP
    Rev Bras Reumatol Engl Ed; 2016; 56(4):287-98. PubMed ID: 27476621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury.
    Assous N; Allanore Y; Batteux F; Meune C; Toulon P; Weill B; Kahan A
    Clin Exp Rheumatol; 2005; 23(2):199-204. PubMed ID: 15895890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in clinical presentation and incidence of cardiopulmonary involvement in late-onset versus early-onset systemic sclerosis: inception cohort study.
    Wangkaew S; Phiriyakrit P; Sawangduan V; Prasertwittayakij N; Euathrongchit J
    Int J Rheum Dis; 2018 May; 21(5):1082-1092. PubMed ID: 29673120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience.
    Demir N; Şahin A; Küçükşahin O; Kayacan O; Dinçer İ; Sayın T; Karnak D; Turgay M
    Heart Lung Circ; 2014 Jul; 23(7):667-73. PubMed ID: 24613044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arterial hypertension treated with angiotensin converting enzyme inhibitors and glucocorticoids are independent risk factors associated with decreased glomerular filtration rate in systemic sclerosis.
    Ostojic P; Stojanovski N
    Rheumatol Int; 2017 Mar; 37(3):363-368. PubMed ID: 28008457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
    Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
    Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demography, clinical and laboratory features of systemic sclerosis in a Malaysian rheumatology centre.
    Pagalavan L; Ong SG
    Med J Malaysia; 2007 Jun; 62(2):117-21. PubMed ID: 18705442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is pulmonary arterial hypertension really a late complication of systemic sclerosis?
    Hachulla E; Launay D; Mouthon L; Sitbon O; Berezne A; Guillevin L; Hatron PY; Simonneau G; Clerson P; Humbert M;
    Chest; 2009 Nov; 136(5):1211-1219. PubMed ID: 19429720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme.
    Morrisroe K; Stevens W; Sahhar J; Rabusa C; Nikpour M; Proudman S;
    Arthritis Res Ther; 2017 Mar; 19(1):42. PubMed ID: 28270192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment for Pulmonary Artery Hypertension Using Clinical and Echocardiographic Criteria in Patients With Systemic Sclerosis.
    Methia N; Latreche S; Ait Mokhtar O; Monsuez JJ; Benkhedda S
    Am J Med Sci; 2016 Oct; 352(4):343-347. PubMed ID: 27776714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis.
    Hong P; Pope JE; Ouimet JM; Rullan E; Seibold JR
    J Rheumatol; 2004 Mar; 31(3):508-13. PubMed ID: 14994396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
    Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
    Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune Diseases in Systemic Sclerosis Patients and Their Relatives: Data from a Single Center.
    Balbir-Gurman A; Shataylo V; Braun-Moscovici Y
    Isr Med Assoc J; 2019 Jan; 21(1):29-34. PubMed ID: 30685902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
    Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
    Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestations.
    Thakkar V; Patterson KA; Stevens W; Wilson M; Roddy J; Sahhar J; Proudman S; Hissaria P; Nikpour M
    Clin Rheumatol; 2018 Jun; 37(6):1563-1571. PubMed ID: 29687288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions.
    Yuen SY; Rochwerg B; Ouimet J; Pope JE
    J Rheumatol; 2008 Jun; 35(6):1073-8. PubMed ID: 18412305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
    Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
    Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
    Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease.
    Terrier B; Tamby MC; Camoin L; Guilpain P; Bérezné A; Tamas N; Broussard C; Hotellier F; Humbert M; Simonneau G; Guillevin L; Mouthon L
    Ann Rheum Dis; 2010 Feb; 69(2):428-33. PubMed ID: 19293162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
    Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
    J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.